Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Craig Rogers who wrote (7537)	4/28/1998 10:50:00 PM
From: DR.TECH	Read Replies (1) \| Respond to of 23519

The large increase in earnings estimates from 1998 to 1999 tells you that the analyst beleive muse will be a viable alternative to viagra. The C/R analyst was smart enough to voice it during the pfe hype. Expect the US fda okay on new facility to be the catalyst for the remaining sheep herders to echo on muse. When this occurs the stock will not be coming from lows and will be the begining of it move upward...Of yes, remember they do have a date...and sentiment has changed..................